Matthews Judith M.
Insider CIK 1734033 · ITRM Chief Financial Officer · ETON Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 32,246 | — | $0 | 32,246 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 32,246 | — | $0 | 32,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2023-03-31 | 2023-04-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-03-11 | 2023-03-14 | 6,666 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2023-03-11 | 2023-03-14 | 6,666 | — | $0 | 11,018 | SEC↗ |
| ITRM Iterum Therapeutics plc | F Tax w/h | 2023-03-11 | 2023-03-14 | 2,883 | $0.96 | $2.8K | 8,135 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-03-14 | 2022-03-15 | 47,132 | $0.38 | $17.9K | 81,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-03-14 | 2022-03-15 | 63,340 | $0.31 | $19.6K | 65,292 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-03-11 | 2022-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2022-03-11 | 2022-03-15 | 100,000 | — | $0 | 128,632 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 1,936,000 | — | $0 | 1,936,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-03-11 | 2021-03-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-01-26 | 2021-01-27 | 33,868 | $1.73 | $58.6K | 28,632 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2021-01-25 | 2021-01-27 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-09-30 | 2020-10-02 | 56,130 | $1.64 | $92.1K | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-02-15 | 2019-02-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 3,038 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 10,980 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 2,466 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 10,980 | — | $0 | 46,626 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 3,038 | — | $0 | 49,664 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 4,000 | $13.00 | $52.0K | 56,130 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 2,466 | — | $0 | 52,130 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 23,870 | — | $0 | 23,870 | SEC↗ |